HyperInflammation and Skin Destruction Mediated by Rosiglitazone Activation
Hyper-Inflammation and Skin Destruction Mediated by Rosiglitazone Activation of Macrophages in IL-6 Deficiency Lopa M. Das, Julie Rosenjack, Liemin Au, Pia S. Galle, Morten B. Hansen, Martha K. Cathcart, Thomas S. Mc. Cormick, Kevin D. Cooper, Roy L. Silverstein, Kurt Q. Lu J Invest Dermatol Volume 135 Issue 2 Pages 389 -399 (February 2015) DOI: 10. 1038/jid. 2014. 375 Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
Figure 1 J Invest Dermatol 2015 135389 -399 DOI: (10. 1038/jid. 2014. 375) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
Figure 2 J Invest Dermatol 2015 135389 -399 DOI: (10. 1038/jid. 2014. 375) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
Figure 3 J Invest Dermatol 2015 135389 -399 DOI: (10. 1038/jid. 2014. 375) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
Figure 4 J Invest Dermatol 2015 135389 -399 DOI: (10. 1038/jid. 2014. 375) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
Figure 5 J Invest Dermatol 2015 135389 -399 DOI: (10. 1038/jid. 2014. 375) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
Figure 6 J Invest Dermatol 2015 135389 -399 DOI: (10. 1038/jid. 2014. 375) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions
- Slides: 7